Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that different patterns of hair thickness and scalp changes can help diagnose types of non-scarring hair loss.

A boy's hair grew back after he stopped using orthodontic headgear that caused temporary hair loss.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

A 35-year-old man had patchy hair loss that was actually due to syphilis, not alopecia areata.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

A child with a rare scalp condition regrew hair after treatment.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Only skin melanocytes, not other types, can color hair in mice.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

The document details hair transplantation techniques and innovations, highlighting Follicular Unit Transplantation as the standard and discussing the effectiveness and challenges of the procedure.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Non-coding RNAs help control hair growth in cashmere goats.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

A rare skin disorder, Ichthyosis with confetti, has no cure but treatment focuses on managing symptoms with moisturizers.